Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon Alfa in Recurrent Unresectable and Malignant Meningiomas
NCT00002965Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 1997
- Primary completion
- Mar 2003
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa in meningioma, hemangiopericytoma (HPC), sponsored by University of Texas MD Anderson Cancer Center. Started Jan 1997; status: completed.
02
Drugs
interferon alfa
03
Conditions
meningiomahemangiopericytoma (HPC)
Beyond the preview
Go deeper on NCT00002965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002965.